Intravenous Immunoglobulin Use in Patients with Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.7, Iss.6, 2006-01, pp. : 359-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

By Fritsch P.O. Sidoroff A.

American Journal of Clinical Dermatology, Vol. 1, Iss. 6, 2000-11 ,pp. : 349-360

Adis International

Access to resources Recommend Favorite

Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide

Clinical Case Reports, Vol. 6, Iss. 2, 2018-02 ,pp. : 258-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlap due to Oral Temozolomide and Cranial Radiotherapy

By Sarma Nilendu

American Journal of Clinical Dermatology, Vol. 10, Iss. 4, 2009-06 ,pp. : 264-267

Adis International

Access to resources Recommend Favorite

Incidence of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in an HIV Cohort: An Observational, Retrospective Case Series Study

By Mittmann Nicole

American Journal of Clinical Dermatology, Vol. 13, Iss. 1, 2012-02 ,pp. : 49-54

Adis International

Access to resources Recommend Favorite

Intravenous Immunoglobulin-Induced, Non-Eczematous, Vesiculobullous Eruptions in Stevens-Johnson Syndrome

By Lin Wan-Lung

American Journal of Clinical Dermatology, Vol. 10, Iss. 5, 2009-10 ,pp. : 339-342

Adis International

Access to resources Recommend Favorite